Genetic diagnosis of patients with esophageal cancer using FISH

Oncology Letters

Volumn 1, Issue 5, 2010, Pages 809-813

  Awut, Idiris ^a   Niyaz, Madiniyet ^a   Huizhong, Xie ^a   Biekemitoufu, Hadeti ^a   Yan, Hong Zhang ^a   Zhu, Zhang ^a   Sheyhedin, Ilyar ^a   Changmin, Zhang ^a   Wei, Zhangli ^a   Wen, Hao ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Aneusomy; Esophageal cancer; Fluorescence in situ hybridization; Pathology

Indexed keywords

BARIUM;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CENTROMERE; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COPY NUMBER VARIATION; DNA PROBE; ESOPHAGUS CANCER; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

EID: 77957564949     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000142     Document Type: Article

References (19)

1. Zhang YM: Distribution of esophageal cancer in the Xinjiang. XMU Med 11: 139-145, 1988.
2. Odze RD: Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol 6: 478-490, 2009.
3. Yerian L: Histology of metaplasia and dysplasia in Barrett's esophagus. Surg Oncol Clin N Am 18: 411-422, 2009.
4. Rajagopalan H and Lengauer C: Aneuploidy and cancer. Nature 432: 338-341, 2004.
5. Halling KC and Kipp BR: Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38: 1137-1144, 2007.
6. Fritcher EG, Brankley SM, Kipp BR, et al: A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus. Hum Pathol 39: 1128-1135, 2008.
7. Doak SH, Jenkins GJS, Parry EM, Griffiths AP, Shah V, Baxter JN and Parry JM: Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br J Cancer 89: 1729-1735, 2003.
8. Nakamura H, Saji H, Idiris A, et al: Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens of non-small cell lung cancer is associated with poor survival. Clin Cancer Res 9: 2294-2299, 2003.
9. Dey P: Aneuploidy and malignancy: an unsolved equation. J Clin Pathol 57: 1245-1249, 2004.
10. Albertson DG, Collins C and McCormick F: Chromosome aberrations in solid tumors. Nat Genet 34: 369-376, 2003.
11. Bahmanyar S and Ye W: Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden. Nutr Cancer 54: 171-178, 2006.
12. Varshney D, Zhou YY, Geller SA and Alsabeh R: Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing Hercep Test and PathVysion FISH assay. Am J Clin Pathol 121: 70-77, 2004.
13. Han QY, Shun H, Yu PW, et al: [Application of multicolor fluorescence in situ hybridization to early diagnosis of esophageal squamous cell carcinoma]. Ai Zheng 27: 396-401, 2008.
14. You XY, Johannes F, Shuang LX and Chiang JL: Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patients. Cell Cycle 13: 1443-1447, 2006.
15. Idiris A, Nakamura H, Maidiniyeti N, et al: Detection of lung cancer cells in bronchial washings using fluorescence in situ hybridization. J Jpn Bronchoesophagol Soc 56: 470-475, 2005.
16. Nakamura H, Idiris A, Kawasaki N, et al: Quantitative detection of lung cancer cells by fluorescence in situ hybridization: comparison with conventional cytology. Chest 128: 906-911, 2005.
17. Reichelt U, Duesedau P, Tsourlakis M, et al: Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Mod Pathol 20: 120-129, 2007.
18. Arnold D, Peinert S, Voigt W and Schmoll HJ: Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review. Oncologist 11: 602-611, 2006.
19. Kawaguchi Y, Kono K, Mimura K, Mitsui F, Sugai H, Akaike H and Fujii H: Targeting EGFR and HER-2 with cetuximab and trastuzumab-mediated immunotherapy in esophageal squamous cell carcinoma. Br J Cancer 97: 494-501, 2007.